Cytogam
NDC 49591-532, HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN, liquid, from Kamada Ltd..
- Product NDC
- 49591-532
- Status
- Listed
- Labeler
- Kamada Ltd.
- Dosage form
- LIQUID
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA103189
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49591-532 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN2500 mg/50mL
Pharmacologic classes
Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]; Virus Neutralization [MoA]; Virus-specific Hyperimmune Globulins [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49591-532-51 | 49591053251 | 1 VIAL, GLASS in 1 CARTON (49591-532-51) / 50 mL in 1 VIAL, GLASS (49591-532-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=49591-532
Use it
Look up 49591-532 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49591-532 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49591-532. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.